focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Spain approves AstraZeneca COVID-19 vaccine for 18-55 year-olds

Fri, 05th Feb 2021 17:38

(Recasts to lead with vaccine approval)

MADRID, Feb 5 (Reuters) - Spain approved AstraZeneca's
coronavirus vaccine for use in people aged 18 to 55 on
Friday, becoming the latest country to limit the shot to younger
people due to a lack of data on its use among the elderly.

Italy also recommends its preferential use for adults of 55
and under, while Germany, France, Austria and Norway will only
administer the shot to people younger than 65.

Separately, Madrid confirmed on Friday the region's first
case of the Brazilian COVID-19 variant, while the national
health ministry said it was not aware of any other cases of the
highly contagious strain on Spanish territory.

Catalan authorities announced Spain's second known case of
the South African variant on Wednesday, a day after the
government restricted air travel with Brazil and South Africa to
curb the spread of the virulent new strains from those
countries.

A third wave of COVID-19 infections has been slowing, with
Spain's 14-day incidence rate falling to 751 cases per 100,000
people on Friday from 900 cases in late January, but officials
say the arrival of the new strains could drive a resurgence.

The health ministry recorded 28,565 new cases on Friday,
bringing the total above 2.94 million, while the death toll
climbed by 584 to 61,386.

"IT'S VERY CONFUSING"

In an initial phase aimed at protecting care-home residents
and workers and front-line medics, Spain has administered 1.87
million doses produced by Pfizer and Moderna.

It expects a delivery of 1.8 million AstraZeneca doses in
February to speed up the pace of inoculation and help it hit a
target of vaccinating 70% of the population by summer.

Nearly three quarters of Spaniards are willing to receive a
shot as soon as one became available, according to a poll by the
Centre for Sociological Studies (CIS) but some remain wary.

"At the moment I will not get one. I will wait a bit," said
80-year old retired lawyer Livigno, out walking in central
Madrid. "You hear positive and negative comments and it's very
confusing. I am not even sure the government is clear."

In one rare bit of good news from the COVID frontline, two
patients recovering from the virus, Fernando, 70, and Rosario,
62, got married at Madrid's Hospital Isabel Zendal after he
proposed to her via WhatsApp. They were married by a priest via
videolink.

(Reporting by Nathan Allen and Graham Keeley
Editing by Ingrid Melander and Gareth Jones)

More News
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.